RT Book, Section
A1 Damon, Lloyd E.
A1 Andreadis, Charalambos Babis
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184166012
T1 Polycythemia Vera
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184166012
RD 2024/04/18
AB Key  Clinical  Updates  in  Polycythemia  VeraRopeginterferon  alfa-2b  was  approved  by  the  European  Medicines  Agency  as  first-line  therapy  for  patients  with  polycythemia  vera  without  symptomatic  splenomegaly.